Crown Electrokinetics Changes Fiscal Year End

TL;DR

Crown Electrokinetics is changing its fiscal year end to Dec 31.

AI Summary

Crown Electrokinetics Corp. filed an 8-K on January 28, 2025, reporting a change in its fiscal year end to December 31. This filing also includes information regarding Regulation FD disclosure and financial statements, with its principal executive offices located at 1110 NE Circle Blvd, Corvallis, Oregon.

Why It Matters

A change in fiscal year end can impact reporting schedules and financial analysis, potentially affecting investor perception and investment decisions.

Risk Assessment

Risk Level: low — This filing primarily concerns administrative changes to the company's fiscal reporting, not significant operational or financial events.

Key Players & Entities

• Crown Electrokinetics Corp. (company) — Registrant
• January 28, 2025 (date) — Date of earliest event reported
• December 31 (date) — New Fiscal Year End
• 1110 NE Circle Blvd, Corvallis, Oregon 97330 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.0001 — ge on which registered Common Stock, $0.0001 par value CRKN NASDAQ Capital Marke

Filing Documents

• ea0227848-8k_crown.htm (8-K) — 30KB
• ea022784801ex3-1_crown.htm (EX-3.1) — 8KB
• ea022784801ex99-1_crown.htm (EX-99.1) — 10KB
• 0001213900-25-007260.txt ( ) — 226KB
• crkn-20250128.xsd (EX-101.SCH) — 3KB
• crkn-20250128_lab.xml (EX-101.LAB) — 33KB
• crkn-20250128_pre.xml (EX-101.PRE) — 22KB
• ea0227848-8k_crown_htm.xml (XML) — 4KB

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 28, 2025 Crown Electrokinetics Corp. (Exact name of registrant as specified in its charter) Delaware 001-39924 47-5423944 (State or other Jurisdiction of Incorporation) (Commission File No.) (IRS Employer Identification No.) 1110 NE Circle Blvd. Corvallis , Oregon 97330 (Address of principal executive offices and zip code) ( 458 ) 212-2500 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value CRKN NASDAQ Capital Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On January 28, 2025, Crown Electrokinetics Corp. (the "Company") filed a Certificate of Amendment (the "Certificate of Amendment") to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of its issued common stock, par value $0.0001 per share ("Common Stock"), in the ratio of 1-for-150 (the "Reverse Stock Split") to be effective at 11:59 p.m. eastern on January 29, 2025. The Common Stock will begin trading on a split-adjusted basis at the market open on Thursday, January 30, 2025. The Reverse Stock Split and the form of Certificate of Amendment were previously approved by the Company's Board of Directors and the Company's stockholders. The new CUSIP number for the Common Stock following the Reverse Stock Split is 228339 503. No fractional shares will be issued as a result of the Reverse Stock Split. Instead, any fractional shares that would have resulted from the Reverse Stock Split will be rounded up to the next whole number. The Reverse Stock Split affects all stockholders uniformly and will not alter any stockholder's percentage interest in the Company's outstanding Common Stock, except for adjustments that may result from the treatment of fractional shares. The number of authorized shares of Common Stock of the Company and number of authorized, issued, and outstanding shares of the preferred stock of the Company were not changed. The above description of the Certificate of Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated by reference herein. Item 7.01. Regulation FD Disclosure. On January 28, 2025, the Company issued a press release announcing the Reverse Stock Split. A copy of the press release is furnished herewith as Exhibit 99.1 to the Current Report on Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD. Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 3.1 Certificate of Amendme

View Full Filing

View this 8-K filing on SEC EDGAR